Page 44 - Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine
P. 44

Li et al. Stem Cell Research & Therapy          (2019) 10:278                           Page 7 of 10





            protein and nucleic acid contents, the research of exo-  highly purified exosomes with stable functional efficacy.
            some biomarkers for eye diseases appears to have suffi-  Exosome research in the eye is still a relatively young
            ciently hopeful prospects.                        field, awaiting more extensive investigations into the
                                                              precise biological mechanisms and clinical potential of
                                                              exosomes in ocular diseases.
            Exosomes as drug delivery vesicles
            The conventional route of treatment for eye disease,
                                                              Abbreviations
            especially involving the anterior segment, is topical in-
                                                              AAV-2: Adeno-associated virus type 2; AH: Aqueous humor; AMD: Age-
            stillation of eye drops, which is accompanied with limita-  related macular degeneration; AQP5: Aquaporin 5; BAFF: B cell activating
            tions such as the need for frequent administration and  factor; BBB: Blood-brain barrier; CFH: Complement factor H; CNV: Choroidal
                                                              neovascularization; DCs: Dendritic cells; EAU: Experimental autoimmune
            low bioavailability. During recent years, various synthetic
                                                              uveoretinitis; EBV: Epstein-Barr virus; ESCRT: Endosomal sorting complex
            drug vehicles have been developed for encasing existing  required for transport; EVs: Extracellular vesicles; FH: Factor H; FHL-1: Factor H
            drugs to enhance the therapeutic effect [111]. However,  like 1; HMGB1: High-mobility group box 1; hUC-MSC-Exos: Human umbilical
                                                              cord-derived MSC-Exos; IFN: Interferon; ILV: Intraluminal vesicles;
            troubling issues including their immunotoxicity [112]
                                                              iNOS: Inducible nitric oxide synthase; IRBP: Interphotoreceptor retinoid-
            and quick clearance by the mononuclear phagocyte sys-  binding protein; LGs: Lacrimal glands; MHC: Major histocompatibility
            tem (MPS) or the reticuloendothelial system (RES) [113]  complex; MPS: Mononuclear phagocyte system; MSC-Exos: Mesenchymal
                                                              stem cells-derived exosomes; MSCs: Mesenchymal stem cells;
            still exist. Fortunately, exosomes, regarded as natural
                                                              MVBs: Multivesicular bodies; NK: Natural killer; PD-L1: Programmed death-
            nanocarriers, have plenty of the highly desired qualities  ligand 1; RES: Reticuloendothelial system; RNPs: Ribonucleoproteins;
            that drug delivery vehicles should have. These small ves-  RPE: Retinal pigment epithelium; SGECs: Salivary gland epithelial cells;
                                                              SNARE: Soluble N-ethylmaleimide-sensitive fusion attachment protein
            icles are capable of penetrating the blood-brain barrier
                                                              receptor; SNPs: Single nucleotide polymorphisms; SS: Sjögren’s syndrome;
            (BBB), delivering their cargoes across cell membranes  STIM1: Stromal interacting molecule 1; TLRs: Toll-like receptors;
            and targeting specific cell types after artificial modifica-  Tregs: Regulatory T cells; TSG101: Tumor susceptibility gene 101;
                                                              VEGF: Vascular endothelial growth factor; VH: Vitreous humor
            tions [114]. Collectively, exosomes have been shown to
            serve as possible nanocarriers for functional RNA
                                                              Acknowledgements
            strands (mRNA, miRNA, siRNA, and lncRNA), DNA     The authors would like to thank the National Natural Science Foundation of
            molecules, peptides, or synthetic drugs [115, 116]. For  China (81770901, 81570834), the Scientific Research Foundation for the
            instance, exosomes from adeno-associated virus type 2  Returned Overseas Chinese Scholars, State Education Ministry (No. 48), and
                                                              the Tianjin Clinical Key Discipline Project (TJLCZDXKT003). The authors would
            (AAV-2)-producing 293 T cells showed higher efficiency  like to thank Tianjin Medical University Eye Hospital, Eye Institute, for its
            in retinal transduction than conventional AAV-2 after  supports in developing this paper.
            intravitreal injection and were regarded as robust tools
            for intravitreal gene transfer into the retina [117]. Be-  Authors’ contributions
            sides, MSC-Exos loaded with exogenous miRNA-126   NL read the literature related to the topic and participated in drafting the
                                                              manuscript. LZ and YW participated in searching and archived the literature
            were reported to alleviate hyperglycemia-induced retinal  related to the topic and discussed the contents of the manuscript. VE revised
            inflammation via suppressing the high-mobility group  the manuscript. HN and RW participated in the design, revision, and final
            box 1 (HMGB1) signal pathway [66]. Moreover, chemo-  approval of the manuscript. All authors read and approved the final
                                                              manuscript.
            therapeutic drug-loaded exosomes showed higher effi-
            cacy and better bioavailability compared to free drug
                                                              Authors’ information
            [118, 119], which sheds new light on ocular pharma-  Na Li, Postgraduate, is studying in Tianjin Key Laboratory of Retinal Functions
            cotherapeutics. So far, there has been sparse research  and Diseases, Eye Institute and School of Optometry, Tianjin Medical
                                                              University Eye Hospital, No. 251, Fukang Road, Nankai District, Tianjin 300384,
            focused on the latent role of loading exosomes with
                                                              China. Lu Zhao, Postgraduate, is studying in Tianjin Key Laboratory of Retinal
            exogenous functional cargoes in eye diseases. Therefore,  Functions and Diseases, Eye Institute and School of Optometry, Tianjin
            significant endeavors are needed to develop such therap-  Medical University Eye Hospital, No. 251, Fukang Road, Nankai District, Tianjin
                                                              300384, China. Yankai Wei, Ph.D., candidate, is studying in Tianjin Key
            ies in ophthalmology.
                                                              Laboratory of Retinal Functions and Diseases, Eye Institute and School of
                                                              Optometry, Tianjin Medical University Eye Hospital, No. 251, Fukang Road,
                                                              Nankai District, Tianjin 300384, China. Vicki L. Ea, Researcher, is working in
            Conclusions                                       Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute and
            Taken together, the extensive implication of exosomes  School of Optometry, Tianjin Medical University Eye Hospital, No. 251,
                                                              Fukang Road, Nankai District, Tianjin 300384, China. Her research focus was
            in regulating various aspects of the immunity makes
                                                              on diabetic retinopathy. Hong Nian, PhD, is a Principal Investigator in Tianjin
            exosomes attractive diagnostic and therapeutic candi-  Key Laboratory of Retinal Functions and Diseases, Eye Institute and School of
            dates for immune-mediated eye diseases (Fig. 2).  Optometry, Tianjin Medical University Eye Hospital, No. 251, Fukang Road,
                                                              Nankai District, Tianjin 300384, China. She focused on studying the
            Because of their multiple functions, elucidating the
                                                              mechanisms of autoimmune diseases, including autoimmune dacryoadenitis
            contents of exosomes and understanding how each of  and autoimmune uveitis. Ruihua Wei, MD, Chief Consultant, is working in
            them function are necessary. Additionally, for success-  Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute and
                                                              School of Optometry, Tianjin Medical University Eye Hospital, No. 251,
            ful translation into clinical therapies, novel and
                                                              Fukang Road, Nankai District, Tianjin 300384, China. She is engaged in the
            advanced technology is urgently needed to obtain mass  diagnosis and treatment of ocular surface diseases and myopia.
   39   40   41   42   43   44   45   46   47   48   49